These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 10471145)
1. Elevated serum alkaline phosphatase may enable early diagnosis of ovarian cancer. Ben-Arie A; Hagay Z; Ben-Hur H; Open M; Dgani R Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):69-71. PubMed ID: 10471145 [TBL] [Abstract][Full Text] [Related]
2. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours. Stigbrand T; Riklund K; Tholander B; Hirano K; Lalos O; Stendahl U Eur J Gynaecol Oncol; 1990; 11(5):351-60. PubMed ID: 2097151 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay of placental alkaline phosphatase in ovarian cancer sera and tissues. Mano H; Furuhashi Y; Morikawa Y; Hattori SE; Goto S; Tomoda Y Obstet Gynecol; 1986 Dec; 68(6):759-64. PubMed ID: 3024085 [TBL] [Abstract][Full Text] [Related]
4. [Detection of placental alkaline phosphatase in ovarian cancer]. Wang R; Song L; Ding L Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):107-9. PubMed ID: 8758806 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis. Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569 [TBL] [Abstract][Full Text] [Related]
6. Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers. Heinonen PK; Kallioniemi OP; Koivula T Tumori; 1987 Jun; 73(3):301-2. PubMed ID: 3474819 [TBL] [Abstract][Full Text] [Related]
7. Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer. Fisken J; Leonard RC; Shaw G; Bowman A; Roulston JE J Clin Pathol; 1989 Jan; 42(1):40-5. PubMed ID: 2921344 [TBL] [Abstract][Full Text] [Related]
8. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma. Vergote IB; Abeler VM; Børmer OP; Stigbrand T; Tropé C; Nustad K Tumour Biol; 1992; 13(3):168-74. PubMed ID: 1626181 [TBL] [Abstract][Full Text] [Related]
9. The expression of placental alkaline phosphatase (PLAP) and PLAP-like enzymes in normal and neoplastic human tissues. An immunohistological survey using monoclonal antibodies. Hamilton-Dutoit SJ; Lou H; Pallesen G APMIS; 1990 Sep; 98(9):797-811. PubMed ID: 2171580 [TBL] [Abstract][Full Text] [Related]
10. Human placental alkaline phosphatase in benign and malignant ovarian neoplasia. Nouwen EJ; Pollet DE; Schelstraete JB; Eerdekens MW; Hänsch C; Van de Voorde A; De Broe ME Cancer Res; 1985 Feb; 45(2):892-902. PubMed ID: 3967249 [TBL] [Abstract][Full Text] [Related]
11. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study. Jacobsen GK; Nørgaard-Pedersen B Acta Pathol Microbiol Immunol Scand A; 1984 Sep; 92(5):323-9. PubMed ID: 6209917 [TBL] [Abstract][Full Text] [Related]
13. Placental type alkaline phosphatase tissue expression in ovarian serous carcinoma. Orsaria M; Londero AP; Marzinotto S; Di Loreto C; Marchesoni D; Mariuzzi L Cancer Biomark; 2016; 17(4):479-486. PubMed ID: 27802199 [TBL] [Abstract][Full Text] [Related]
14. Serum placental-type alkaline phosphatase activity in women with squamous and glandular malignancies of the reproductive tract. Ind TE; Iles RK; Carter PG; Lowe DG; Shepherd JH; Hudson CN; Chard T J Clin Pathol; 1994 Nov; 47(11):1035-7. PubMed ID: 7829680 [TBL] [Abstract][Full Text] [Related]
15. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma. Ward BG; Cruickshank DJ; Tucker DF; Love S Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease. Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570 [TBL] [Abstract][Full Text] [Related]
17. Biological markers and ovarian carcinomas: galactosyltransferase, CA 125, isoenzymes of amylase and alkaline phosphatase. Sichel F; Salaün V; Bar E; Gauduchon P; Malas JP; Goussard J; Le Talaër JY Clin Chim Acta; 1994 Jun; 227(1-2):87-96. PubMed ID: 7525119 [TBL] [Abstract][Full Text] [Related]
18. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers. Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805 [TBL] [Abstract][Full Text] [Related]
19. Immunohistology of normal and ovarian cancer tissue with a monoclonal antibody to placental alkaline phosphatase. Sunderland CA; Davies JO; Stirrat GM Cancer Res; 1984 Oct; 44(10):4496-502. PubMed ID: 6467208 [TBL] [Abstract][Full Text] [Related]
20. Placenta-like alkaline phosphatase in gynecological cancers. Kellen JA; Bush RS; Malkin A Cancer Res; 1976 Jan; 36(1):269-71. PubMed ID: 1248005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]